Description: Tsumura & Co. engages in the manufacture and sale of pharmaceutical products worldwide. The company offers Kampo extract intermediates and granular Kampo formulations. It is involved in the procurement, selection and processing, and storage of raw material crude drugs and crude drug pieces for decoction; manufacture of Kampo powdered extracts and traditional Chinese medicines; and sale of pharmaceuticals and food products. The company was founded in 1893 and is headquartered in Tokyo, Japan.
Home Page: www.tsumura.co.jp
2-17-11, Akasaka
Tokyo,
107-8521
Japan
Phone:
81 3 6361 7101
Officers
| Name | Title |
|---|---|
| Mr. Terukazu Kato | Pres, CEO & Representative Director |
| Mr. Muneki Handa | CFO & Director |
| Mr. Koin Toda | Co-Chief Operating Officer |
| Mr. Susumu Adachi | Co-COO & Director |
| Mr. Kei Sugii | Co-COO & Director |
| Mr. Ryouichi Murata | Head of Sales & Marketing Division and Exec. Officer |
| Mr. Shuji Sugawara | Exec. Officer & Head of HR |
| Shuichi Takeda | Head of Reliability Assurance Division and Sr. Exec. Officer |
| Mr. Ryuji Takasaki | Managing Exec. Officer and Head of Kampo Scientific Strategies Division |
| Mr. Kimitoshi Usui | Head of Production Division and Exec. Officer |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 13.0548 |
|---|---|
| Trailing PE: | 13.599 |
| Price-to-Book MRQ: | 1.1807 |
| Price-to-Sales TTM: | 0.0157 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 0 |